ArticleScientific reports2015

A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms.

Ying-Chyi Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.